Table 1 Immunohistochemical analysis of... | American Society of Hematology

Table 1

Immunohistochemical analysis of metastatic melanoma lesions

	Cell counts per 10 high-power field
	Intratumoral lymphocytes		Peritumoral lymphocytes
	Responders (n = 11)	Nonresponders (n = 9)	Responders (n = 11)	Nonresponders (n = 9)
CD4⁺, total ± SEM	142 ± 39	75 ± 18	587 ± 153	475 ± 69
FOXP3⁺ CD4⁺, total ± SEM	33 ± 8	26 ± 8	101 ± 28	90 ± 16
FOXP3⁺/CD4⁺, % ± SEM	24 ± 4	30 ± 6	17 ± 2	19 ± 2
CD8⁺, total ± SEM	263 ± 53	170 ± 54	476 ± 89	448 ± 79
FOXP3⁺ CD8⁺, total ± SEM	0.6 ± 0.2	0.6 ± 0.3	1.4 ± 0.9	2.3 ± 0.7
FOXP3⁺/CD8⁺, % ± SEM	0.2 ± 0.1	0.3 ± 0.2	0.2 ± 0.1	0.4 ± 0.1

	Cell counts per 10 high-power field
	Intratumoral lymphocytes		Peritumoral lymphocytes
	Responders (n = 11)	Nonresponders (n = 9)	Responders (n = 11)	Nonresponders (n = 9)
CD4⁺, total ± SEM	142 ± 39	75 ± 18	587 ± 153	475 ± 69
FOXP3⁺ CD4⁺, total ± SEM	33 ± 8	26 ± 8	101 ± 28	90 ± 16
FOXP3⁺/CD4⁺, % ± SEM	24 ± 4	30 ± 6	17 ± 2	19 ± 2
CD8⁺, total ± SEM	263 ± 53	170 ± 54	476 ± 89	448 ± 79
FOXP3⁺ CD8⁺, total ± SEM	0.6 ± 0.2	0.6 ± 0.3	1.4 ± 0.9	2.3 ± 0.7
FOXP3⁺/CD8⁺, % ± SEM	0.2 ± 0.1	0.3 ± 0.2	0.2 ± 0.1	0.4 ± 0.1